// App-Quantinova.ai

P399 : Vedolizumab therapy results in reduced hospitalisation and steroid use over 1-year: Results from the Scottish vedolizumab consortium

Researchers

Presenter

  • N Plevris

Principal Investigators

  • R Allen

  • P Baker

  • P Brennan

  • A Churchhouse

  • E Donoghue

  • D Gaya

  • H Jafferbhoy

  • P Jenkinson

  • G Jones

  • J Macdonald

  • M MacMaster

  • C Mowat

  • G Naismith

  • L Potts

  • E Saffouri

  • J P Seenan

  • A Sengupta

  • P Shasi

  • J Todd

  • J Veryan

  • A Watson

  • D Watts

  • I Arnott

  • C Lees

  • M Groome

Medical Centers

  • NHS Lothian, Gastroenterology, Edinburgh, United Kingdom

  • NHS Greater Glasgow and Clyde, Gastroenterology, Glasgow, UK

  • NHS Tayside, Gastroenterology, Dundee, United Kingdom

  • NHS Forth Valley, Gastroenterology, Forth Valley, UK

  • NHS Fife, Gastroenterology, Kirkcaldy, UK

  • NHS Lanarkshire, Gastroenterology, Lanarkshire, UK

  • NHS Highlands, Gastroenterology, Inverness, UK

  • NHS Highlands, Colorectal Surgery, Inverness, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A